Shripad V. Bhagwat - Concepedia

Author

Shripad V. Bhagwat

Also Known As

Johnson, Gary L, S Bhagwat, S V Bhagwat, S. Bhagwat, S.V. Bhagwat, Seema K. Bhagwat, Shripad Bhagwat, Shripad V Bhagwat, Shripad V. Bhagwat

310

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Pennsylvania National Institute of Mental Health and Neurosciences Eli Lilly (Spain)National Cancer Institute

About

Shripad V. Bhagwat is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	707
2	Biochemistry	8	8	241
3	Natural Sciences	4	4	163
4	Social Sciences	3	3	219
5	Health Sciences	1	1	12

Shripad V. Bhagwat

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
CD13/APN is activated by angiogenic signals and is essential for capillary tube formation Shripad V. Bhagwat, Johanna Lahdenranta, Ricardo J. Giordano, Blood	2001	344
Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin Shripad V. Bhagwat, Prafulla C. Gokhale, Andrew P. Crew, Molecular Cancer Therapeutics	2011	200
Targeting of NH2-terminal–processed Microsomal Protein to Mitochondria: A Novel Pathway for the Biogenesis of Hepatic Mitochondrial P450MT2 Sankar Addya, Hindupur K. Anandatheerthavarada, Gopa Biswas, The Journal of Cell Biology	1997	138
Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets Ying Chen, Jeremy McGee, Xian‐Ming Chen, PLoS ONE	2014	135
Preferential effects of nicotine and 4-(N-methyl- N-nitrosamino)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase a4-4 induction and increased oxidative stress in the rat brain Shripad V. Bhagwat, Camasamudram Vijayasarathy, Haider Raza, Biochemical Pharmacology Reductive StressMitochondrial FunctionNeurophysiologyMedicineNicotine	1998	126
The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis Shripad V. Bhagwat, Nenad Petrović, Yasuhiro Okamoto, Blood	2003	106
ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine Shripad V. Bhagwat, William T. McMillen, Shufen Cai, Molecular Cancer Therapeutics	2019	101
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers Irem Ozkan‐Dagliyan, J. Nathaniel Diehl, Samuel D. George, Cell Reports Kras Mutant CancersApoptosisCell DeathCancer BiologyTumor Biology	2020	97
RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1 S-H Chen, Xutong Gong, Y Zhang, Oncogene Tumor BiologyCdk4/6 InhibitionCyclin D1MedicinePharmacology	2017	72
CD13/APN Transcription Is Induced by RAS/MAPK-mediated Phosphorylation of Ets-2 in Activated Endothelial Cells Nenad Petrović, Shripad V. Bhagwat, William J. Ratzan, Journal of Biological Chemistry Endothelial CellsActivated Endothelial CellsImmunologyCellular PhysiologyInflammation	2003	63

Page 1